256 related articles for article (PubMed ID: 17487385)
1. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
[TBL] [Abstract][Full Text] [Related]
2. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
3. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
5. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Nemes JA; Deli L; Nemes Z; Márton IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
7. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil.
Li W; Thompson CH; Cossart YE; O'Brien CJ; McNeil EB; Scolyer RA; Rose BR
Head Neck; 2004 Jan; 26(1):1-9. PubMed ID: 14724900
[TBL] [Abstract][Full Text] [Related]
8. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
9. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
12. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium.
Horn LC; Richter CE; Einenkel J; Tannapfel A; Liebert UG; Leo C
Ann Diagn Pathol; 2006 Aug; 10(4):193-6. PubMed ID: 16844559
[TBL] [Abstract][Full Text] [Related]
13. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma.
Tsuda H; Yamamoto K; Inoue T; Uchiyama I; Umesaki N
Br J Cancer; 2000 Feb; 82(3):675-82. PubMed ID: 10682682
[TBL] [Abstract][Full Text] [Related]
14. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
Liu JH; Huang H; Huang X; Zeng MS; Li W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523
[TBL] [Abstract][Full Text] [Related]
15. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
Lerma E; Esteller M; Herman JG; Prat J
Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
19. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
20. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
Greer RO; Meyers A; Said SM; Shroyer KR
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]